Reducing Tumour Hypoxia via Oral Administration of Oxygen Nanobubbles.
Hypoxia has been shown to be a key factor inhibiting the successful treatment of solid tumours. Existing strategies for reducing hypoxia, however, have shown limited efficacy and/or adverse side effects. The aim of this study was to investigate the potential for reducing tumour hypoxia using an oral...
Saved in:
| Main Authors: | , , , , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Public Library of Science (PLoS)
2016-01-01
|
| Series: | PLoS ONE |
| Online Access: | https://journals.plos.org/plosone/article/file?id=10.1371/journal.pone.0168088&type=printable |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| _version_ | 1849467515670888448 |
|---|---|
| author | Joshua Owen Conor McEwan Heather Nesbitt Phurit Bovornchutichai Raymond Averre Mark Borden Anthony P McHale John F Callan Eleanor Stride |
| author_facet | Joshua Owen Conor McEwan Heather Nesbitt Phurit Bovornchutichai Raymond Averre Mark Borden Anthony P McHale John F Callan Eleanor Stride |
| author_sort | Joshua Owen |
| collection | DOAJ |
| description | Hypoxia has been shown to be a key factor inhibiting the successful treatment of solid tumours. Existing strategies for reducing hypoxia, however, have shown limited efficacy and/or adverse side effects. The aim of this study was to investigate the potential for reducing tumour hypoxia using an orally delivered suspension of surfactant-stabilised oxygen nanobubbles. Experiments were carried out in a mouse xenograft tumour model for human pancreatic cancer (BxPc-3 cells in male SCID mice). A single dose of 100 μL of oxygen saturated water, oxygen nanobubbles or argon nanobubbles was administered via gavage. Animals were sacrificed 30 minutes post-treatment (3 per group) and expression of hypoxia-inducible-factor-1α (HIF1α) protein measured by real time quantitative polymerase chain reaction and Western blot analysis of the excised tumour tissue. Neither the oxygen saturated water nor argon nanobubbles produced a statistically significant change in HIF1α expression at the transcriptional level. In contrast, a reduction of 75% and 25% in the transcriptional and translational expression of HIF1α respectively (p<0.001) was found for the animals receiving the oxygen nanobubbles. This magnitude of reduction has been shown in previous studies to be commensurate with an improvement in outcome with both radiation and drug-based treatments. In addition, there was a significant reduction in the expression of vascular endothelial growth factor (VEGF) in this group and corresponding increase in the expression of arrest-defective protein 1 homolog A (ARD1A). |
| format | Article |
| id | doaj-art-b5f4e39f1fe145db8a8595a12febe938 |
| institution | Kabale University |
| issn | 1932-6203 |
| language | English |
| publishDate | 2016-01-01 |
| publisher | Public Library of Science (PLoS) |
| record_format | Article |
| series | PLoS ONE |
| spelling | doaj-art-b5f4e39f1fe145db8a8595a12febe9382025-08-20T03:26:10ZengPublic Library of Science (PLoS)PLoS ONE1932-62032016-01-011112e016808810.1371/journal.pone.0168088Reducing Tumour Hypoxia via Oral Administration of Oxygen Nanobubbles.Joshua OwenConor McEwanHeather NesbittPhurit BovornchutichaiRaymond AverreMark BordenAnthony P McHaleJohn F CallanEleanor StrideHypoxia has been shown to be a key factor inhibiting the successful treatment of solid tumours. Existing strategies for reducing hypoxia, however, have shown limited efficacy and/or adverse side effects. The aim of this study was to investigate the potential for reducing tumour hypoxia using an orally delivered suspension of surfactant-stabilised oxygen nanobubbles. Experiments were carried out in a mouse xenograft tumour model for human pancreatic cancer (BxPc-3 cells in male SCID mice). A single dose of 100 μL of oxygen saturated water, oxygen nanobubbles or argon nanobubbles was administered via gavage. Animals were sacrificed 30 minutes post-treatment (3 per group) and expression of hypoxia-inducible-factor-1α (HIF1α) protein measured by real time quantitative polymerase chain reaction and Western blot analysis of the excised tumour tissue. Neither the oxygen saturated water nor argon nanobubbles produced a statistically significant change in HIF1α expression at the transcriptional level. In contrast, a reduction of 75% and 25% in the transcriptional and translational expression of HIF1α respectively (p<0.001) was found for the animals receiving the oxygen nanobubbles. This magnitude of reduction has been shown in previous studies to be commensurate with an improvement in outcome with both radiation and drug-based treatments. In addition, there was a significant reduction in the expression of vascular endothelial growth factor (VEGF) in this group and corresponding increase in the expression of arrest-defective protein 1 homolog A (ARD1A).https://journals.plos.org/plosone/article/file?id=10.1371/journal.pone.0168088&type=printable |
| spellingShingle | Joshua Owen Conor McEwan Heather Nesbitt Phurit Bovornchutichai Raymond Averre Mark Borden Anthony P McHale John F Callan Eleanor Stride Reducing Tumour Hypoxia via Oral Administration of Oxygen Nanobubbles. PLoS ONE |
| title | Reducing Tumour Hypoxia via Oral Administration of Oxygen Nanobubbles. |
| title_full | Reducing Tumour Hypoxia via Oral Administration of Oxygen Nanobubbles. |
| title_fullStr | Reducing Tumour Hypoxia via Oral Administration of Oxygen Nanobubbles. |
| title_full_unstemmed | Reducing Tumour Hypoxia via Oral Administration of Oxygen Nanobubbles. |
| title_short | Reducing Tumour Hypoxia via Oral Administration of Oxygen Nanobubbles. |
| title_sort | reducing tumour hypoxia via oral administration of oxygen nanobubbles |
| url | https://journals.plos.org/plosone/article/file?id=10.1371/journal.pone.0168088&type=printable |
| work_keys_str_mv | AT joshuaowen reducingtumourhypoxiaviaoraladministrationofoxygennanobubbles AT conormcewan reducingtumourhypoxiaviaoraladministrationofoxygennanobubbles AT heathernesbitt reducingtumourhypoxiaviaoraladministrationofoxygennanobubbles AT phuritbovornchutichai reducingtumourhypoxiaviaoraladministrationofoxygennanobubbles AT raymondaverre reducingtumourhypoxiaviaoraladministrationofoxygennanobubbles AT markborden reducingtumourhypoxiaviaoraladministrationofoxygennanobubbles AT anthonypmchale reducingtumourhypoxiaviaoraladministrationofoxygennanobubbles AT johnfcallan reducingtumourhypoxiaviaoraladministrationofoxygennanobubbles AT eleanorstride reducingtumourhypoxiaviaoraladministrationofoxygennanobubbles |